These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Large lymphadenopathies complicating the abacavir hypersensitivity reaction. García JT; González PR; Hernández-Mora MG; Novoa SR; Quintana FB; Lahoz JG; Vázquez VS AIDS; 2007 Oct; 21(16):2254-6. PubMed ID: 18090059 [No Abstract] [Full Text] [Related]
7. Parsonage-Turner syndrome: a rare case of abacavir hypersensitivity reaction in HIV-infected patients. Bellagamba R; Tommasi C; De Marco M; Narciso P J Infect; 2008 Jul; 57(1):88-90. PubMed ID: 18514915 [No Abstract] [Full Text] [Related]
8. Hypersensitivity reactions due to abacavir. Newsline People AIDS Coalit N Y; 1998 Feb; ():35-6. PubMed ID: 11367446 [TBL] [Abstract][Full Text] [Related]
9. Warning against rechallenge with abacavir. AIDS Patient Care STDS; 1998 Mar; 12(3):229. PubMed ID: 11361938 [No Abstract] [Full Text] [Related]
10. Newly approved abacavir to carry hypersensitivity warning. Miller JL Am J Health Syst Pharm; 1999 Feb; 56(4):304. PubMed ID: 10690211 [No Abstract] [Full Text] [Related]
11. Prospective HLA-B*5701 screening and abacavir hypersensitivity: a single centre experience. Waters LJ; Mandalia S; Gazzard B; Nelson M AIDS; 2007 Nov; 21(18):2533-4. PubMed ID: 18025891 [TBL] [Abstract][Full Text] [Related]
12. Comment: Abacavir hypersensitivity reaction: an update. Hughes CA; Foisy MM; Dewhurst N; Higgins N; Robinson L; Kelly DV; Lechelt KE Ann Pharmacother; 2008 Oct; 42(10):1519-20; author reply 1520-1. PubMed ID: 18780810 [No Abstract] [Full Text] [Related]
13. Abacavir warning. AIDS Patient Care STDS; 2000 Nov; 14(11):617. PubMed ID: 11155904 [No Abstract] [Full Text] [Related]
14. A near-fatal hypersensitivity reaction to abacavir: case report and literature review. Shapiro M; Ward KM; Stern JJ AIDS Read; 2001 Apr; 11(4):222-6. PubMed ID: 11392679 [TBL] [Abstract][Full Text] [Related]
15. Hypersensitivity related to abacavir in two members of a family. Peyrieère H; Nicolas J; Siffert M; Demoly P; Hillaire-Buys D; Reynes J Ann Pharmacother; 2001 Oct; 35(10):1291-2. PubMed ID: 11675863 [No Abstract] [Full Text] [Related]
16. 1592 (abacavir): do not rechallenge after hypersensitivity reaction. James JS AIDS Treat News; 1997 Dec; (No 285):1, 5. PubMed ID: 11364916 [TBL] [Abstract][Full Text] [Related]
17. Abacavir hypersensitivity reaction. AIDS Patient Care STDS; 2002 May; 16(5):242. PubMed ID: 12058699 [No Abstract] [Full Text] [Related]
18. Unusual clinical presentation of hypersensitivity reaction to abacavir. Aquilina C; Mularczyk M; Lucas F; Viraben R AIDS; 2003 Nov; 17(16):2403-4. PubMed ID: 14571198 [No Abstract] [Full Text] [Related]
19. Development of abacavir hypersensitivity reaction after rechallenge in a previously asymptomatic patient. El-Sahly HM AIDS; 2004 Jan; 18(2):359-60. PubMed ID: 15075569 [No Abstract] [Full Text] [Related]
20. Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV cohort study. Rauch A; Nolan D; Martin A; McKinnon E; Almeida C; Mallal S Clin Infect Dis; 2006 Jul; 43(1):99-102. PubMed ID: 16758424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]